Bruce Keyt
2018
In 2018, Bruce Keyt earned a total compensation of $352.3K as Chief Scientific Officer at IGM Biosciences.
Compensation breakdown
| Salary | $352,222 |
|---|---|
| Total | $352,333 |
Keyt received $352.2K in salary, accounting for 100% of the total pay in 2018.
Rankings
In 2018, Bruce Keyt's compensation ranked 12,848th out of 14,244 executives tracked by ExecPay. In other words, Keyt earned more than 9.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,848 out of 14,244 | 10th |
Division Manufacturing | 5,197 out of 5,762 | 10th |
Major group Chemicals And Allied Products | 1,956 out of 2,125 | 8th |
Industry group Drugs | 1,677 out of 1,814 | 8th |
Industry Pharmaceutical Preparations | 1,285 out of 1,388 | 7th |
Source: SEC filing on April 21, 2020.
Keyt's colleagues
We found one more compensation record of an executive who worked with Bruce Keyt at IGM Biosciences in 2018.
2018
Fred Schwarzer
IGM Biosciences
Chief Executive Officer
News
IGM Biosciences CEO Fred Schwarzer's 2022 pay falls 46% to $5.3M
April 27, 2023
IGM Biosciences CEO Fred Schwarzer's 2021 pay jumps 94% to $9.9M
April 27, 2022
IGM Biosciences CEO Fred Schwarzer's 2020 pay jumps 574% to $5.1M
April 29, 2021
IGM Biosciences CEO Fred Schwarzer's 2019 pay jumps 46% to $757K
April 21, 2020